# Tempest Therapeutics, Inc.: Form 8-K, filed May 2, 2022

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K
- Filed: 2022-05-02
- Accepted by EDGAR: May 2, 2022, 08:02 ET
- Period: 2022-04-26
- Accession: 0001193125-22-135401
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000119312522135401/d212050d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000119312522135401/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000119312522135401/d212050d8k.htm

Filed May 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-135401. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
